King Law has years of experience handling complex cases and is knowledgeable about legal action involving adverse health reactions related to treatment with GLP-1 receptor agonists
Teschke R, Uetrecht J (2021) Mechanism of idiosyncratic drug induced liver injury (DILI): Unresolved basic issues
A chamber with more collagen is not the same as a demonstrated improvement in a human condition, and the leap from a molecular or tissue-level change to a meaningful health benefit is exactly the leap that clinical trials exist to test and that has not been made for this route
Global cancer control: responding to the growing burden, rising costs and inequalities in access
If you develop a persistent, unexplained change in bowel habit particularly if you are aged 40 or over or have other risk factors your GP may wish to assess you in line with NICE guidance on suspected cancer (NG12), which sets out referral thresholds for persistent bowel changes
While the weight loss associated with semaglutide is likely one factor in the reduction of cardiac events, the studys authors saw the number of events go down even before maximum weight loss occurr ed
